Exhibit 10.13
AMENDMENT NO. 1 TO THE
EXCLUSIVE LICENSE AGREEMENT
THIS AMENDMENT effective as of the 30th day of day of September 2004
(hereinafter "Amendment"), amends the Exclusive License Agreement dated May 19,
2003 ("Agreement") by and between ILEX Products, Inc. (ILEX") and QuatRx
Pharmaceuticals Company ("QuatRx").
WHEREAS, the Parties desire to amend the Agreement to eliminate ILEX's
commitment to provide product liability insurance coverage under Section 10.1 of
the Agreement.
NOW, THEREFORE, the Agreement Is hereby amended as follows:
In Section 10.1, the final sentence of the Section is modified to read as
follows:
"Such comprehensive, general liability Insurance shall be limited to broad
form contractual liability coverage (not including product liability
coverage), for ILEX's indemnification of Licensee under Section 9.1 of this
Agreement."
IN WITNESS WHEREOF, the parties hereto have caused the forgoing Amendment
to be executed by their respective representatives.
Accepted for Accepted for
QuatRx Pharmaceuticals Company ILEX Products, Inc.
/s/ Xxxx Onn /s/ Xxxxxxx X. Xxxxx
------------------------------------- ----------------------------------------
Name: Xxxx Onn Name: Xxxxxxx X. Xxxxx
Title: CFO Title: Senior VP, Business Management
Date: 11-11-04 Date: 11-11-04
EXECUTION COPY
